Information Library

Clinical and marketing materials

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by:
  • Most Recent
  • Title

  • The New Health Clinical Brochure

    August 31, 2010
    Japanese version available for download.

  • THE NEW HEALTH REPORT REVEALS PERCEPTION GAPS AMONG BIOPHARMA STAKEHOLDERS

    June 15, 2010 - Newly published report details the differences between bio pharma and other key stakeholders as they grapple with industry challenges.

  • Brand Solutions

    June 8, 2010
    There are fi ve practical ways you can use our Brand Solutions expertise to increase the value of your brand.

  • Clinical – smarter trials, accelerated outcomes

    April 2, 2010
    Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues.

  • Commercial – identify, promote and prove treatment value

    April 1, 2010
    Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success.

  • QUINTILES SPEEDS PATIENT RECRUITMENT WITH LOCAL MARKETING AUTOMATION TECHNOLOGY

    Quintiles today launched innovative, web-based technology to enable world-class marketing for clinical trial enrollment at an individual site-level. Named Quintiles Trial Enrollment Accelerator (QTEA), this new solution will speed patient recruitment by helping customers better manage the quality, consistency and effectiveness of messaging and media outreach.

  • QUINTILES EXECUTIVE ELECTED CHAIR-ELECT OF CDISC

    January 19, 2010 – Quintiles announced that Paula Brown Stafford, Executive Vice President, Integrated Clinical Services, has been elected chair-elect of the Board of Directors of CDISC, a global organization that leads the development of standards to reduce complexity in biomedical research to speed new therapies to market and improve the flow of research information to healthcare.

  • Emerging Markets

    September 29, 2009
    If you’re looking for new ways to bring development costs down, you may be considering the advantages of conducting clinical trials in emerging markets.

  • Treatment Satisfaction Questionnaire

    September 25, 2009
    When evaluating the quality of programs, services, and products, patient satisfaction is a useful patient reported outcome. It serves four interrelated but distinct purposes, permitting: 1) evaluation of the acceptability of care or treatments from the patients’ perspective; 2) comparison of health-care programs or treatment options; 3) identification of service or treatment approaches that require change; 4) screening of patients who are likely to become nonadherent to care plans or medication regimens For these reasons, satisfaction measures are often used to plan health-care delivery systems and develop pharmaceutical products or medical devises.

  • Patient Registries: A Taxonomy for the Design, Development and Implementation

    June 25, 2009
    Recommendations from the ISPOR Patient Registry Classification, Strategy & Design Working Group, Team 2, for developing standard language for the characterization, classification, strategy, design, and execution of patient registries to generate data for outcomes research purposes.

Page 1 of 4 (32 results)

Subscribe to Email Based on Your Interests

Set preferences